Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments.
ImmunityBio's stock has risen sharply this year. Read more on whether investors should look closely at shares or avoid the ...
In vivo, using the subcutaneous MB49 bladder cancer model, HSV5-15 virus expressing both the cytokine and TLR agonist ...
Researchers in Japan found that food antigens like milk proteins suppress tumor growth in the small intestines by activating ...
Researchers developed a pan-immune-inflammation–based nomogram to accurately predict overall survival (OS) and ...
In Depth
Mayo Clinic on MSN19hIn Depth
COVID-19 vaccines: Get the facts
Catching the virus that causes COVID-19 or getting a COVID-19 vaccination gives you protection, also called immunity, from the virus. But over time, that protection seems to ...
Over the past few decades, there have been major advancements in cancer treatment, with more focused and less harmful choices ...
A new study from OHSU is claiming to show promise in the treatment of what they are calling an "urgent, unmet need" in cancer ...
Hyundai dealers in New England created a charity to fund pediatric cancer research. Today, Hyundai Hope on Wheels is ...